I'm cautiously optimistic about this development though I have a lot of questions.
I don't know enough about medical negligence for example to understand the threshold of proof.
I'm also curious about the numbers. Getting to 1000 appears feasible in theory but I simply don't think we have the data on how many of the 19k went on to take PB's.
Equally, what validity any waivers signed wrt risk/side effects may/may not have.
I'm in no doubt that PB's are dangerous drugs but we are still afaik lacking proper data on their impact. Is that very lack of data significant in the context of them being prescribed as the risks could never be fully understood?
However, the fact we are at this point might make a lot of people pause moving forward.
Continuing to supply such drugs with a class action pending surely must make the NHS at least re-think its position, even in the context of the Cass report and the decision to close GIDS.